Pathogenicity of Sporotrichum pruninosum and Cladosporium oxysporum, isolated from the bronchial secretions of a patient, for laboratory mice.
In this study we have demonstrated the occurrence of Sporotrichum pruinosum and Cladosporium oxysporum in the bronchial secretions of a patient with a presumptive diagnosis of tuberculosis. This observation coupled with the ability of both fungi to cause infection and elicit tissue responses in experimentally infected mice supported a probable etiologic relationship with the patient which could not be confirmed in the absence of histologic evidence. In vitro some antimycotics were tested against S. pruinosum and C. oxysporum by the agar dilution method. Oxiconazole with a minimum inhibitory concentration of 0.1 micrograms/ml-1 after 72 h and amorolfine at a concentration of 0.001 micrograms/ml-1 after 72 h were the most active ones against S. pruinosum and C. oxysporum respectively. It is suggested that the isolation of S. pruinosum and C. oxysporum from patients with bronchopulmonary disorders should be viewed with caution. Clinical and laboratory evaluation of such patients should be done critically before arriving at a firm diagnosis.
Singh
S M
SM
Department of Biological Sciences, Rani Durgavati University, Jabalpur, India.
Singh
M
M
Mukherjee
S
S
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology; D001980:Bronchi / Q000382:microbiology*; D001991:Bronchitis / Q000382:microbiology*; D002963:Cladosporium / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D013175:Sporothrix / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D013183:Sputum / Q000382:microbiology*
D000935:Antifungal Agents